Search results
Growing demand for weight loss treatments drives sales at drugmaker Novo Nordisk
PA Media: Money via Yahoo Finance· 2 hours agoIt is a newly available treatment in the UK so is still monitored closely. Demand for Wegovy...
Stock market today: Starbucks, Trump Media shares up pre-market
Newsweek· 2 hours agoU.S. futures were slightly up on Thursday, after Wednesday saw a mixed ending for major indexes...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 1 hour agoFood and Drug Administration (FDA) has completed its 30-day review of the investigational new drug (IND) application for the use of bremelanotide, a melanocortin receptor 4 agonist (MCR4), for ...
Novo Nordisk sales jump on strong demand for obesity drug
Investing.com· 8 hours agoNovo Nordisk (NYSE: NVO ) reported a robust first quarter with a 24% increase in sales at constant...
Weight-loss drug maker Novo Nordisk's profits soar further
AFP via Yahoo Finance· 3 hours agoDanish pharmaceutical giant Novo Nordisk reported more soaring profits on Thursday thanks to the...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 4 hours agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Why Markets Must Beware Powell’s Comments on Fed Rate Hikes, and 5 Other Things to Know Today
Barrons.com· 2 hours agoNovo Nordisk hikes guidance as sales of weight-loss drugs surge, Qualcomm profit lifted amid high...
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Qualcomm, Apple, DoorDash, Zillow,...
Barrons.com· 1 hour agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
North American Morning Briefing: Stock Futures Rise as More Earnings Roll In
Morningstar· 3 hours agoStock futures pointed higher on Thursday and bond yields fell as the market continued to express relief that the Federal Reserve's latest monetary policy meeting passed without ...
Eli Lilly soars 8% after Q1 earnings reveal surging popularity for its Zepbound weight-loss drug
Business Insider via Yahoo Finance· 2 days agoAs we continue to make pipeline investments that position us forfuture growth, we are rapidly...